Therapeutic time window of disease-modifying therapy for early Alzheimer's disease.

Alzheimers Dement (N Y) · 2025 · PMC12122261 · PMID 40453977

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

The tau status in Braak 3/4 or 5/6 regions assessed by tau‐PET, which was available only in ADNI cases, showed only a marginally significant association with longer eligibility duration. 3.4.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.